tiprankstipranks
Trending News
More News >
Ocular Therapeutix (OCUL)
NASDAQ:OCUL
US Market

Ocular Therapeutix (OCUL) Technical Analysis

Compare
1,429 Followers

Technical Sentiment

Overall Consensus
Strong Buy
15Bullish
5Neutral
2Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Ocular Therapeutix’s (OCUL) Moving Averages Convergence Divergence (MACD) indicator is 0.36, suggesting Ocular Therapeutix is a Sell.
Ocular Therapeutix’s (OCUL) 20-Day exponential moving average is 8.79, while Ocular Therapeutix’s (OCUL) share price is $9.46, making it a Buy.
Ocular Therapeutix’s (OCUL) 50-Day exponential moving average is 8.30, while Ocular Therapeutix’s (OCUL) share price is $9.46, making it a Buy.

Ocular Therapeutix (OCUL) Pivot Points

Jul 04, 2025, 12:06 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
8.59
8.82
8.96
9.19
9.33
9.56
9.70
Fibonacci
8.82
8.96
9.05
9.19
9.33
9.42
9.56
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Ocular Therapeutix (OCUL) Moving Averages

Jul 04, 2025, 12:06 AM
Period
Simple
Exponential
MA5
9.30Buy
9.24Buy
MA10
8.96Buy
9.07Buy
MA20
8.84Buy
8.79Buy
MA50
8.13Buy
8.30Buy
MA100
7.70Buy
8.09Buy
MA200
8.48Buy
8.38Buy
Ocular Therapeutix’s (OCUL) 10-Day exponential moving average is 9.07, while Ocular Therapeutix’s (OCUL) share price is $9.46, making it a Buy.
Ocular Therapeutix’s (OCUL) 100-Day exponential moving average is 8.09, while Ocular Therapeutix’s (OCUL) share price is $9.46, making it a Buy.
Ocular Therapeutix’s (OCUL) stock price is $9.46 and Ocular Therapeutix’s (OCUL) 50-day simple moving average is 8.13, creating a Buy signal.
Ocular Therapeutix’s (OCUL) stock price is $9.46 and Ocular Therapeutix’s (OCUL) 100-day simple moving average is 7.70, creating a Buy signal.
Ocular Therapeutix’s (OCUL) stock price is $9.46 and Ocular Therapeutix’s (OCUL) 200-day simple moving average is 8.48, creating a Buy signal.

Ocular Therapeutix (OCUL) Technical Indicators

Jul 04, 2025, 12:06 AM
Name
Value
Implied Action
RSI (14)
63.57
Neutral
STOCH (9,6)
63.45
Neutral
STOCHRSI (14)
63.45
Neutral
MACD (12,26)
0.36
Sell
ADX (14)
30.56
Neutral
Williams %R
-27.41
Buy
CCI (14)
107.55
Sell
ATR (14)
0.54
-
Ultimate Oscillator
53.33
Neutral
ROC
7.26
Buy
Ocular Therapeutix’s (OCUL) Relative Strength Index (RSI) is 63.57, creating a Neutral signal.
Ocular Therapeutix’s (OCUL) Trend Strength Indicator (ADX) is 30.56, creating a Neutral signal.
Ocular Therapeutix’s (OCUL) Commodity Channel Index (CCI) is 107.55, creating a Sell signal.
Ocular Therapeutix’s (OCUL) Price Rate of Change (ROC) is 7.26, creating a Buy signal.

FAQ

Is OCUL a Buy, Hold, or Sell?
Based on OCUL’s technical indicators, OCUL is a Strong Buy.
    What is OCUL’s RSI (14)?
    OCUL’s RSI (14) is 63.57, which suggests OCUL is a Neutral.
      What is OCUL’s MACD?
      OCUL’s MACD is 0.36, which suggests OCUL is a Sell.
        What is OCUL’s 5-day moving average?
        OCUL’s 5-day moving average is 9.30, which suggests OCUL is a Buy.
          What is OCUL’s 20-day moving average?
          OCUL 20-day moving average is 8.84, which suggests OCUL is a Buy.
            What is OCUL’s 50-day moving average?
            OCUL’s 50-day moving average is 8.13, which suggests OCUL is a Buy.
              What is OCUL’s 200-day moving average?
              OCUL’s 200-day moving average is 8.48, which suggests OCUL is a Buy.
                What is OCUL’s Williams % R (14)?
                OCUL’s Williams % R (14) is -27.41, which suggests OCUL is a Buy.
                  What is OCUL’s CCI (14)?
                  OCUL’s CCI (14) is 107.55, which suggests OCUL is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis